{"id":17123,"date":"2023-05-03T09:44:07","date_gmt":"2023-05-03T07:44:07","guid":{"rendered":"https:\/\/www.pharmaforum.be\/news\/penuries-de-medicaments-en-europe-il-faut-du-temps\/"},"modified":"2023-07-11T14:56:46","modified_gmt":"2023-07-11T12:56:46","slug":"medicijntekorten-in-europa-dat-kost-tijd","status":"publish","type":"news","link":"https:\/\/www.pharmaforum.be\/nl\/news\/medicijntekorten-in-europa-dat-kost-tijd\/","title":{"rendered":"Medicijntekorten in Europa, dat kost tijd&#8230;"},"content":{"rendered":"<p>Sinds eind 2022 melden EU-landen ernstige problemen bij het inkopen van bepaalde belangrijke geneesmiddelen, waarbij een meerderheid nu effectief tekorten ervaart.<br \/>\nIn een enqu\u00eate over geneesmiddelentekorten die tussen 14 november en 31 december 2022 werd uitgevoerd door de Farmaceutische Groep van de Europese Unie (EU), meldde 100% van de 29 lidstaten tekorten aan geneesmiddelen te hebben onder apothekers en 76% zei dat de tekorten erger waren dan het voorgaande jaar, 2021.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medicijntekorten zijn de belangrijkste uitdaging waar apotheken mee worstelen, voor het vierde opeenvolgende jaar &#8211; duizelingwekkende statistieken!<\/p>\n","protected":false},"featured_media":17132,"template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_api_id":"46728","_exhibitors":["16739"],"footnotes":""},"edition":[451],"country":[],"class_list":["post-17123","news","type-news","status-publish","has-post-thumbnail","hentry","edition-pharma-forum-2023"],"_links":{"self":[{"href":"https:\/\/www.pharmaforum.be\/nl\/wp-json\/wp\/v2\/news\/17123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmaforum.be\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.pharmaforum.be\/nl\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":2,"href":"https:\/\/www.pharmaforum.be\/nl\/wp-json\/wp\/v2\/news\/17123\/revisions"}],"predecessor-version":[{"id":17130,"href":"https:\/\/www.pharmaforum.be\/nl\/wp-json\/wp\/v2\/news\/17123\/revisions\/17130"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmaforum.be\/nl\/wp-json\/wp\/v2\/media\/17132"}],"wp:attachment":[{"href":"https:\/\/www.pharmaforum.be\/nl\/wp-json\/wp\/v2\/media?parent=17123"}],"wp:term":[{"taxonomy":"edition","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/nl\/wp-json\/wp\/v2\/edition?post=17123"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/nl\/wp-json\/wp\/v2\/country?post=17123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}